tiprankstipranks
Trending News
More News >
Advertisement

GRPM - ETF AI Analysis

Compare

Top Page

GRPM

Invesco S&P MidCap 400 GARP ETF (GRPM)

Rating:74Outperform
Price Target:
GRPM, the Invesco S&P MidCap 400 GARP ETF, earns a solid overall rating largely because many of its top holdings like Permian Resources, TechnipFMC, and Renaissancere show strong financial performance, positive earnings calls, and generally supportive technical trends. Some positions such as Halozyme and Kinsale Capital Group introduce risks with bearish technical signals and high leverage or segment challenges, and the fund’s focus on a specific slice of mid-cap growth-at-a-reasonable-price stocks means investors are exposed to sector- and style-specific swings rather than a broad market mix.
Positive Factors
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Strong Top Holdings Momentum
Several of the largest positions, such as Rambus, TechnipFMC, Hamilton Lane, Medpace, and Pilgrim's Pride, have delivered strong year-to-date gains that support the fund’s performance.
Diversified Mid-Cap Sector Mix
Holdings spread across financials, technology, energy, consumer sectors, health care, and industrials help reduce the impact of weakness in any single industry.
Negative Factors
High U.S. Market Concentration
With almost all assets invested in U.S. companies, the fund offers little geographic diversification and is heavily tied to the U.S. market.
Sector Concentration in Financials
A large tilt toward financial stocks increases the fund’s sensitivity to problems specific to the financial sector.
Mixed Performance Among Top Holdings
Some key positions like Lantheus, Renaissancere, and AppFolio have shown weak year-to-date performance, which can drag on overall returns if the weakness continues.

GRPM vs. SPDR S&P 500 ETF (SPY)

GRPM Summary

The Invesco S&P MidCap 400 GARP ETF (GRPM) tracks the S&P MidCap 400 GARP Index, focusing on mid-sized U.S. companies that are growing but not considered too expensive. It holds a mix of sectors like financials, technology, health care, and energy, with companies such as Rambus and TechnipFMC among its top positions. Someone might invest in this ETF to seek long-term growth while spreading risk across many mid-sized companies instead of picking individual stocks. A key risk is that mid-cap stocks can be more volatile than large, well-known companies, so the ETF’s value can rise and fall significantly with the market.
How much will it cost me?The Invesco S&P MidCap 400 GARP ETF (GRPM) has an expense ratio of 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed, focusing on selecting mid-cap stocks with growth potential and reasonable valuations.
What would affect this ETF?The GRPM ETF, focused on mid-sized U.S. companies, could benefit from economic growth and innovation in sectors like technology and healthcare, which are significant parts of its portfolio. However, rising interest rates or economic slowdowns could negatively impact mid-cap stocks, particularly in cyclical sectors like consumer discretionary and financials. Regulatory changes or sector-specific challenges in industries like energy or healthcare may also influence the ETF's performance.

GRPM Top 10 Holdings

GRPM is leaning hard into U.S. mid-cap financials and energy, and that’s where much of the action is. Valaris, TechnipFMC, and Permian Resources have been powering ahead, giving the fund a strong tailwind from the energy patch. On the financial side, Renaissancere and Bank OZK look steady-to-rising, helping offset weakness in Kinsale Capital, which has been losing steam and slightly dragging on results. Lantheus adds a bright spot from health care, but overall this is a domestically focused, mid-cap play with notable bets in financials and energy.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Lantheus3.36%$15.97M$4.69B-31.77%
73
Outperform
Renaissancere Holdings2.97%$14.13M$12.99B22.54%
78
Outperform
Valaris2.80%$13.30M$6.06B134.05%
76
Outperform
Permian Resources2.75%$13.06M$16.90B48.78%
81
Outperform
TechnipFMC2.73%$12.97M$25.21B136.30%
80
Outperform
Carpenter Technology2.53%$12.04M$19.28B114.73%
75
Outperform
Halozyme2.38%$11.31M$7.95B10.48%
73
Outperform
Kinsale Capital Group2.30%$10.95M$8.61B-16.64%
75
Outperform
AppFolio2.26%$10.76M$6.88B-13.45%
71
Outperform
Pilgrim's Pride2.21%$10.50M$9.68B-25.39%
73
Outperform

GRPM Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
122.65
Negative
100DMA
120.69
Negative
200DMA
117.11
Positive
Market Momentum
MACD
-0.51
Positive
RSI
37.57
Neutral
STOCH
29.97
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GRPM, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 122.92, equal to the 50-day MA of 122.65, and equal to the 200-day MA of 117.11, indicating a neutral trend. The MACD of -0.51 indicates Positive momentum. The RSI at 37.57 is Neutral, neither overbought nor oversold. The STOCH value of 29.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GRPM.

GRPM Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$483.69M0.35%
74
Outperform
$855.46M0.38%
70
Neutral
$753.83M0.25%
71
Outperform
$605.21M0.04%
69
Neutral
$406.44M0.24%
70
Outperform
$397.29M0.15%
71
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GRPM
Invesco S&P MidCap 400 GARP ETF
118.70
15.89
15.46%
EZM
WisdomTree U.S. MidCap Fund
XMLV
Invesco S&P MidCap Low Volatility ETF
BKMC
BNY Mellon US Mid Cap Core Equity ETF
JPME
JPMorgan Diversified Return U.S. Mid Cap Equity ETF
QVMM
Invesco S&P MidCap 400 QVM Multi-factor ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement